Article
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor…
OncoTargets and Therapy · 2014 · Smyth EC, Sclafani F, Cunningham D
Key facts
| Title | Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors |
|---|---|
| First author | Smyth EC, Sclafani F, Cunningham D |
| Journal | OncoTargets and Therapy |
| Published | Jun 12, 2014 |
| DOI | 10.2147/OTT.S44941 |
| Devices mentioned | K042152, K770467, K780428, K791373, K801244, K820613, K820614, K820942, K852441, K854177, K854178, K854179 and 11 more |
| Product codes mentioned | CDT, CEO, CFE, CFN, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA and 7 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1